Skip to contentV
Vaccinex, Inc.
V
VCNXVaccinex, Inc. Q1 2021 · 10-Q
Revenue$850.00K$850.00Kno prior Q1 2020 on file Net Income-$6.57M-$6.57MN/M vs Q1 2020 EPS Diluted-$0.26-$0.26N/M vs Q1 2020 Operating Income-$6,240,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaccinex, Inc. · CIK 1205922 · Engraved from SEC EDGAR
Margins · derivedOperating margin-734.1%
Net margin-773.4%
ended Mar 31, 2021 · filed May 17, 2021 · 47 d after period end